Establishment Labs Holdings Inc
NASDAQ:ESTA

Watchlist Manager
Establishment Labs Holdings Inc Logo
Establishment Labs Holdings Inc
NASDAQ:ESTA
Watchlist
Price: 47.28 USD 0.98%
Market Cap: 1.3B USD
Have any thoughts about
Establishment Labs Holdings Inc?
Write Note

Gross Margin
Establishment Labs Holdings Inc

65.1%
Current
66%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
65.1%
=
Gross Profit
99.6m
/
Revenue
153.1m

Gross Margin Across Competitors

Country CR
Market Cap 1.3B USD
Gross Margin
65%
Country JP
Market Cap 7T JPY
Gross Margin
86%
Country CH
Market Cap 37.9B CHF
Gross Margin
55%
Country DK
Market Cap 178.7B DKK
Gross Margin
68%
Country US
Market Cap 16.1B USD
Gross Margin
70%
Country KR
Market Cap 10.3T KRW
Gross Margin
15%
Country CN
Market Cap 49B CNY
Gross Margin
72%
Country US
Market Cap 6.5B USD
Gross Margin
65%
Country CA
Market Cap 6.4B USD
Gross Margin
61%
Country US
Market Cap 5.7B USD
Gross Margin
47%
Country UK
Market Cap 4.6B GBP
Gross Margin
56%
No Stocks Found

Establishment Labs Holdings Inc
Glance View

Market Cap
1.3B USD
Industry
Health Care

Established at the intersection of innovation and aesthetics, Establishment Labs Holdings Inc. has carved a niche in the global medical technology landscape. Founded in 2004, this Costa Rica-based company has painstakingly built a reputation for its cutting-edge silicone breast implants and medical devices aimed at breast aesthetics and reconstruction. The company leverages advanced technology to deliver safer and more natural products, primarily through its signature Motiva Implants® brand. With its commitment to safety, quality, and innovation, Establishment Labs has successfully expanded into more than 80 countries, earning trust by catering to surgeons and patients with an ever-evolving portfolio of aesthetically driven solutions. Establishment Labs’ business model is intricately tied to the nuances of the cosmetic surgery industry, where product differentiation and regulatory compliance are paramount. The company invests heavily in research and development, focusing on creating next-generation breast implant technologies that prioritize patient safety and satisfaction. Revenue streams are driven by direct sales to plastic surgeons and healthcare providers, capitalizing on growing global demand for aesthetic procedures. Additionally, the company stays ahead of the competition by fostering strong relationships with medical professionals and continuously educating them about the benefits and capabilities of its innovative product offerings. This strategic alliance strengthens its market presence and aids consistent revenue growth, reinforcing its status as a forward-thinking leader in the medical aesthetics field.

ESTA Intrinsic Value
25.98 USD
Overvaluation 45%
Intrinsic Value
Price
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
65.1%
=
Gross Profit
99.6m
/
Revenue
153.1m
What is the Gross Margin of Establishment Labs Holdings Inc?

Based on Establishment Labs Holdings Inc's most recent financial statements, the company has Gross Margin of 65.1%.